Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Home›Companies›Oxford Nanopore Technologies
Oxford Nanopore Technologies logo

Oxford Nanopore Technologies

Oxford, United Kingdom Biotech 1,000 employees Founded 2005 ONT nanoporetech.com ↗
＋ Follow
Download profile PDF
6 Products & services
1,000 Employees

About Oxford Nanopore Technologies

Oxford Nanopore is a UK biotech spun out of the University of Oxford, developing real-time, portable DNA/RNA sequencing platforms.

Sector
Biotech
Headquarters
Oxford, United Kingdom
Founded
2005
Employees
1,000

Milestones

Milestones as listed on nanoporetech.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

2005
Founded as Oxford Nanolabs
By Gordon Sanghera, Spike Willcocks and Hagan Bayley with IP Group seed funding.
Source: nanoporetech.com
2009
Company relocates to Oxford Science Park
Source: nanoporetech.com
2012
First-ever nanopore sequencing data presented at AGBT
GridION and MinION systems also outlined.
Source: nanoporetech.com
2014
MinION Access Programme begins
Early users gained access to the MinION.
Source: nanoporetech.com
2017
GridION X5 ships; direct RNA sequencing launched
Source: nanoporetech.com
2019
Harwell, Oxfordshire manufacturing facility comes online
Source: nanoporetech.com
2020
LamPORE COVID-19 test gains CE marking
Company's first diagnostic.
Source: nanoporetech.com
2026
Francis Van Parys succeeds Gordon Sanghera as CEO
Source: nanoporetech.com

Leadership Team

Leadership as listed on nanoporetech.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

Francis Van Parys

Chief Executive Officer
Source: nanoporetech.com

Nick Keher

Chief Financial Officer
Source: nanoporetech.com

Dr. Lakmal Jayasinghe

Chief Scientific Officer
Source: nanoporetech.com

Davide Manissero

Chief Medical Officer
Source: nanoporetech.com

David Miller

Chief Development and Product Officer
Source: nanoporetech.com

Tina St. Leger

Chief People Officer
Source: nanoporetech.com

Products & Services

Products and services as listed on nanoporetech.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

All Sequencing device Consumables Sample preparation Software
Sequencing device

MinION

Portable nanopore sequencer for rapid results.

Source: nanoporetech.com
Sequencing device

GridION

Benchtop sequencer running up to five independent MinION Flow Cells.

Source: nanoporetech.com
Sequencing device

PromethION

High-output nanopore sequencing devices with integrated compute, 2 to 24 flow cells.

Source: nanoporetech.com
Consumables

MinION and PromethION Flow Cells

DNA and direct RNA flow cells for MinION/GridION and PromethION devices.

Source: nanoporetech.com
Sample preparation

Library prep and automation

Kits and automation solutions to prepare samples for nanopore sequencing.

Source: nanoporetech.com
Software

Analysis software

Software and informatics tools for analysing nanopore data.

Source: nanoporetech.com

In the News

No coverage yet — our newsroom tracks Oxford Nanopore Technologies continuously.

Research Publications

EUROPE PMC · LIVE
Searching Europe PMC for affiliated publications...

FDA Recalls (US)

OPENFDA · LIVE
Checking openFDA drug-recall records...